We conduct randomised Phase III trials with large populations and a broad spectrum of therapy areas.
Our model has been crafted to support our sponsors’ needs in the latter stages of drug development.
Number one recruitment site out of 83 centres for a study involving patients with Transthyretin Amyloidosis with Cardiomyopathy. 64 patients were recruited within three months.
Richmond recruited 10% of the total patient volunteers needed for a global heart failure trial in just two months.
Our specialist clinical team has experience in conducting clinical trials with a broad spectrum of patient groups with common and rare diseases.
We are equipped to deliver single centre studies for early phase patient trials.
We have access to specialist consultants, professors and medical practitioners through our academic and medical partnerships.
Our multi-disciplinary team operate in a hospital-style setting which facilitates efficient, safe trial management.
Richmond Pharmacology has a team of experts with extensive knowledge of clinical research trials.
We are on the lookout for people who love what they do, strive for excellence and who want to make a difference.